CN116239615A - Boron-containing organic compound and application thereof - Google Patents

Boron-containing organic compound and application thereof Download PDF

Info

Publication number
CN116239615A
CN116239615A CN202111483347.2A CN202111483347A CN116239615A CN 116239615 A CN116239615 A CN 116239615A CN 202111483347 A CN202111483347 A CN 202111483347A CN 116239615 A CN116239615 A CN 116239615A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
ring
heteroaryl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111483347.2A
Other languages
Chinese (zh)
Inventor
李熠烺
陈春雨
李国孟
刘嵩
贾小琴
孙磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Eternal Material Technology Co Ltd
Original Assignee
Beijing Eternal Material Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Eternal Material Technology Co Ltd filed Critical Beijing Eternal Material Technology Co Ltd
Priority to CN202111483347.2A priority Critical patent/CN116239615A/en
Publication of CN116239615A publication Critical patent/CN116239615A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1055Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Indole Compounds (AREA)

Abstract

The invention relates to a boron-containing organic compound, belongs to the technical field of organic luminescent materials, and also relates to application of the compound in an organic electroluminescent device. The compound has a structure shown in the following formula. Mother nucleus structure of the inventive compound moleculeThe para position in the central benzene ring is connected with two oxygen atoms, and simultaneously connected with two nitrogen atoms and two boron atoms. On the premise of keeping multiple resonances, the energy level split of the front line orbit generates effective red shift, so that the target molecule has high luminous efficiency and high color purity.

Description

Boron-containing organic compound and application thereof
Technical Field
The invention relates to a boron-containing organic compound, belongs to the technical field of organic luminescent materials, and also relates to application of the compound in an organic electroluminescent device.
Background
The main way people acquire information is through vision, so that a display device is important in the process of human interaction with information. Organic Light Emitting Diodes (OLEDs) have many advantages of flexibility, self-luminescence, high contrast, large size, low power consumption, etc., and become one of the currently mainstream display devices.
The red dye and the green dye which are three primary colors can theoretically realize 100% internal quantum efficiency due to the fact that the red dye and the green dye generally contain heavy atoms such as Ir, pt and the like, and are high in electroluminescent efficiency and low in power consumption, so that the red dye and the green dye become the main stream of the current commercial display equipment. However, the chromaticity and lifetime of blue phosphorescent materials are not as good as the current commercial display requirements. Currently, blue light devices still employ conventional fluorescent materials to achieve high color purity and long device lifetime.
Recently, researchers of Japanese Takuji Hatakeyama and Junji Kido et al report a series of organic materials DABA-1 (adv. Mater.2016,28,2777-2781J. Mater. Chem. C,2019,7, 3082-3089) based on TADF (ThermallyActivated Delayed Fluorescence ) of boron-containing resonance type, boron atoms, nitrogen atoms and phenyl groups of the compounds constitute a rigid polycyclic aromatic skeleton, and thus have high fluorescence quantum yield. Compared with the traditional blue fluorescent dye, the compound has narrower spectrum and high color purity. However, the rigid planar structure also causes the energy level difference between the singlet state and the triplet state to be larger, the transition between the triplet state and the singlet state is slower, the exciton is compounded on the dye to cause serious efficiency roll-off, and the service life of the device is shorter. In addition, too planar a rigid structure often results in an adverse effect such as broadening of the spectrum and red shifting due to too high doping concentrations.
Figure BDA0003395719340000011
There is still a great room for improvement in the light emitting performance of the existing organic electroluminescent materials, and there is a need in the industry to develop new luminescent material systems to meet the commercial demands. Boron-containing resonant materials have the advantages of high color purity and high luminous efficiency, and are attracting wide attention in the scientific research and industry. However, since the peripheral substituent has little influence on the energy level, that is, the light color of the material is difficult to regulate and control, the light color of the material is always limited to a blue light-deep blue light area, and the further application of the material in the fields of high-resolution display, full-color display, white light illumination and the like is greatly limited.
Disclosure of Invention
The invention relates to a compound with a general formula, which has a structure shown in a general formula (1):
Figure BDA0003395719340000021
in the formula (1), Y 1 、Y 2 Each independently is N or B;
X 1 、X 2 each independently selected from NR 1 、BR 2 O or S;
ring A, ring D, ring E, ring F are each independently selected from any one of substituted or unsubstituted C6-C60 aromatic rings, substituted or unsubstituted C3-C60 heteroaromatic rings;
R 1 、R 2 each independently selected from any one of substituted or unsubstituted C1-C20 straight or branched chain alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C60 aryl, substituted or unsubstituted C3-C60 heteroaryl, R 1 、R 2 Each independently being unconnected to an adjacent ring structure or connected to form a ring by a chemical bond;
the substituents in ring A, ring D, ring E and ring F are each independently selected from at least one of halogen, unsubstituted or R ' substituted C1-C20 straight or branched alkyl, unsubstituted or R ' substituted C3-C20 cycloalkyl, unsubstituted or R ' substituted C1-C20 alkoxy, unsubstituted or R ' substituted C1-C20 alkylsilyl, unsubstituted or R ' substituted C1-C20 alkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R ' substituted C6-C30 arylamino, unsubstituted or R ' substituted C3-C30 heteroarylamino, unsubstituted or R ' substituted C6-C30 aryloxy, unsubstituted or R ' substituted C3-C30 heteroaryloxy, unsubstituted or R ' substituted C6-C60 aryl and unsubstituted or R ' substituted C3-C60 heteroaryl;
r' is independently selected from any one or a combination of at least two of halogen, C1-C20 straight-chain or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxyl, C1-C20 alkyl silicon base, C1-C20 alkyl amino, C6-C30 aryl amino, C3-C30 heteroaryl amino, C6-C30 aryloxy, C3-C30 heteroaryl oxy, C6-C60 aryl or C3-C60 heteroaryl;
And at least one of the substituted substituents in ring A, ring D, ring E and ring F is a fluorine atom, or at least one R' is one of a fluorine atom substituted C1-C20 straight or branched alkyl group, a fluorine atom substituted C3-C20 cycloalkyl group, a fluorine atom substituted C6-C60 aryl group or a fluorine atom substituted C3-C60 heteroaryl group;
specifically, in formula (1), at least one ring of ring A, ring D, ring E, ring F is substituted with F atom;
or at least one of ring A, ring D, ring E, ring F is substituted with at least one of R ' substituted C1-C20 straight or branched chain alkyl, R ' substituted C3-C20 cycloalkyl, R ' substituted C1-C20 alkoxy, R ' substituted C1-C20 alkylsilyl, R ' substituted C1-C20 alkylamino, R ' substituted C6-C30 arylamino, R ' substituted C3-C30 heteroarylamino, R ' substituted C6-C30 aryloxy, R ' substituted C3-C30 heteroaryloxy, R ' substituted C6-C60 aryl, R ' substituted C3-C60 heteroaryl, and at least one R ' is a fluorine atom, or at least one R ' is a combination of a fluorine atom and any one of C1-C20 straight or branched chain alkyl, C3-C20 cycloalkyl, C6-C60 aryl, or C3-C60 heteroaryl;
The substituents in the ring A, the ring D, the ring E and the ring F are not connected independently, or 2 adjacent substituents are connected through chemical bonds to form a ring;
R 1 、R 2 wherein R' is independently selected from any one or a combination of at least two of halogen, C1-C20 straight-chain or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxyl, C1-C20 alkyl silicon, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroaryl amino, C6-C30 aryloxy, C3-C30 heteroaryl oxy, C6-C60 aryl or C3-C60 heteroaryl.
Further, in formula (1), the Y 1 、Y 2 Are all B; preferably, the X 1 、X 2 At least one of them is NR 1 The method comprises the steps of carrying out a first treatment on the surface of the More preferably, the X 1 、X 2 Are all NR 1
In the present specification, the "substituted or unsubstituted" group may be substituted with one substituent or may be substituted with a plurality of substituents, and when the number of substituents is plural, the substituents may be selected from different substituents, and the same meaning is given when the same expression mode is involved in the present invention, and the selection ranges of the substituents are all shown above and are not repeated.
In the present specification, the expression of Ca to Cb means that the group has a carbon number of a to b, and unless otherwise specified, in general, in the present specification, "each independently" means that the subject has a plurality of subjects, and they may be the same or different from each other.
Heteroatoms in the present specification generally refer to atoms or groups of atoms selected from N, O, S, P, si and Se, preferably N, O, S.
In the present specification, unless otherwise specified, the expression of a chemical element generally includes the concept of isotopes having the same chemical properties, for example, the expression of "hydrogen (H)", and also includes the expression of isotopes having the same chemical properties 1 H (protium or H), 2 The concept of H (deuterium or D); carbon (C) then comprises 12 C、 13 C, etc., and are not described in detail.
In the present specification, examples of halogen include: fluorine, chlorine, bromine, iodine, and the like.
In the present specification, unless otherwise specified, both aryl and heteroaryl include cases of single rings and condensed rings.
In the present specification, the substituted or unsubstituted C6-C60 aryl group includes monocyclic aryl groups and condensed ring aryl groups, preferably C6-C30 aryl groups, and further preferably C6-C20 aryl groups. By monocyclic aryl is meant that the molecule contains at least one phenyl group, and when the molecule contains at least two phenyl groups, the phenyl groups are independent of each other and are linked by a single bond, such as, for example: phenyl, biphenyl, terphenyl, and the like. Specifically, the biphenyl group includes a 2-biphenyl group, a 3-biphenyl group, and a 4-biphenyl group; the terphenyl group includes p-terphenyl-4-yl, p-terphenyl-3-yl, p-terphenyl-2-yl, m-terphenyl-4-yl, m-terphenyl-3-yl and m-terphenyl-2-yl. Condensed ring aryl refers to a group in which at least two aromatic rings are contained in the molecule, and the aromatic rings are not independent of each other but share two adjacent carbon atoms condensed with each other. Exemplary are as follows: naphthyl, anthryl, phenanthryl, indenyl, fluorenyl, fluoranthryl, triphenylenyl, pyrenyl, perylenyl,
Figure BDA0003395719340000031
And a radical, a tetracenyl radical, a derivative thereof, and the like. The naphthyl comprises 1-naphthyl or 2-naphthyl; the anthracenyl is selected from 1-anthracenyl, 2-anthracenyl and 9-anthracenyl; the fluorenyl group is selected from the group consisting of 1-fluorenyl, 2-fluorenyl, 3-fluorenyl, 4-fluorenyl, and 9-fluorenyl; the pyrenyl group is selected from 1-pyrenyl, 2-pyrenyl and 4-pyrenyl; the tetracenyl is selected from the group consisting of 1-tetracenyl, 2-tetracenyl and 9-tetracenyl. The derivative group of the fluorene is selected from 9, 9-dimethylfluorenyl, 9-diethyl fluorenyl, 9-dipropyl fluorenyl, 9-dibutyl fluorenyl 9, 9-dipentylfluorenyl, 9-dihexylfluorenyl, 9-diphenylfluorenyl, 9-dinaphthylfluorenyl, 9' -spirobifluorene, and benzofluorenyl.
The C3-C60 heteroaryl group mentioned in the present specification includes monocyclic heteroaryl groups and condensed ring heteroaryl groups, preferably C3-C30 heteroaryl groups, further preferably C4-C20 heteroaryl groups, and further preferably C5-C12 heteroaryl groups. Monocyclic heteroaryl means that the molecule contains at least one heteroaryl group, and when the molecule contains one heteroaryl group and other groups (such as aryl, heteroaryl, alkyl, etc.), the heteroaryl group and the other groups are independent of each other and are linked by a single bond, and examples of the monocyclic heteroaryl group include: furyl, thienyl, pyrrolyl, pyridyl, and the like. Condensed ring heteroaryl means a group in which at least one aromatic heterocyclic ring and one aromatic ring (aromatic heterocyclic ring or aromatic ring) are contained in a molecule and two adjacent atoms are fused together without being independent of each other. Examples of fused ring heteroaryl groups include: benzofuranyl, benzothienyl, isobenzofuranyl, indolyl, dibenzofuranyl, dibenzothiophenyl, carbazolyl, acridinyl, isobenzofuranyl, isobenzothiophenyl, benzocarbazolyl, azacarbazolyl, phenothiazinyl, phenazinyl, 9-phenylcarbazolyl, 9-naphthylcarbazolyl, dibenzocarbazolyl, indolocarbazolyl, and the like.
Examples of the C6-C30 arylamino group mentioned in the present invention include: phenylamino, methylphenylamino, naphthylamino, anthracenylamino, phenanthrylamino, biphenylamino, and the like.
Examples of the C3-C30 heteroarylamino group mentioned in the present invention include: pyridylamino, pyrimidinylamino, dibenzofuranylamino and the like.
The chain alkyl group mentioned in the present invention includes a straight chain alkyl group and a branched chain alkyl group unless otherwise specified. Specifically, the substituted or unsubstituted C1-C30 chain alkyl group is preferably a substituted or unsubstituted C1-C16 chain alkyl group, more preferably a substituted or unsubstituted C1-C10 chain alkyl group. Examples of the substituted or unsubstituted C1-C10 chain alkyl group include: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 2-methylbutyl, n-pentyl, sec-pentyl, neopentyl, n-hexyl, neohexyl, n-heptyl, n-octyl, 2-ethylhexyl and the like.
In the present invention, the cycloalkyl group includes a monocycloalkyl group and a multicycloalkyl group; wherein, monocycloalkyl refers to an alkyl group having a single cyclic structure; polycycloalkyl refers to a structure in which two or more cycloalkyl groups are formed by sharing one or more ring carbon atoms; examples of the C3-C20 cycloalkyl group include: cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, and the like.
In the present specification, examples of the C1-C10 alkoxy group which is preferably substituted or unsubstituted C1-C20 alkoxy group, and which is preferably substituted or unsubstituted C1-C10 alkoxy group, may be given as follows: methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, tert-butoxy, pentyloxy, isopentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy and the like are preferred, methoxy, ethoxy, n-propoxy, isopropoxy, tert-butoxy, sec-butoxy, isobutoxy, isopentyloxy are more preferred.
Further, the compound of the present invention has a structure as shown in formula (2):
Figure BDA0003395719340000041
in formula (2), ring a, ring D, ring E, ring F have the same defined ranges as in claim 1;
R a 、R b each independently selected from any one of substituted or unsubstituted C1-C20 straight or branched chain alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C60 aryl, and substituted or unsubstituted C3-C60 heteroaryl;
the R is a Not attached to ring E or attached by chemical bonds to form a ring, R b Is not connected with the ring F or is connected with the ring F through a chemical bond to form a ring;
R a 、R b Each of the substituted substituents is independently selected from any one or a combination of at least two of halogen, C1-C20 straight-chain or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl.
Preferably, said R a 、R b Each independently has a structure as shown in formula (B):
Figure BDA0003395719340000042
wherein the dotted line represents the attachment site of the group;
U 1 、U 2 、U 3 、U 4 、U 5 each independently selected from CR 4 Or N;
R 4 each independently selected from any one or a combination of at least two of hydrogen, halogen, C1-C20 straight or branched chain alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl; different R 4 Each independently of the other is not connected or is connected through a chemical bond to form a ring;
preferably, the U 1 、U 2 、U 3 、U 4 、U 5 Four of them are CR 4 The other is N;
or preferably, the U 1 、U 2 、U 3 、U 4 、U 5 Are all CR 4
Further, in the compounds of the general formula (1) or (2), the ring A, the ring D, the ring E and the ring F each independently have a structure as shown in the formula (A),
Figure BDA0003395719340000051
wherein the dashed line represents a fused bond of the group;
Z 1 、Z 2 、Z 3 、Z 4 each independently selected from CR 3 Or N;
R 3 each independently selected from hydrogen, halogen, unsubstituted or R' substituted C1-C20 straight or branched alkyl,Unsubstituted or R 'substituted C3-C20 cycloalkyl, unsubstituted or R' substituted C1-C20 alkoxy, unsubstituted or R 'substituted C1-C20 alkylsilyl, unsubstituted or R' substituted C1-C20 alkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R 'substituted C6-C30 arylamino, unsubstituted or R' substituted C3-C30 heteroarylamino, unsubstituted or R 'substituted C6-C30 aryloxy, unsubstituted or R' substituted C3-C30 heteroaryloxy, unsubstituted or R 'substituted C6-C60 aryl, unsubstituted or R' substituted C3-C60 heteroaryl, and R 3 At least one of which is a fluorine atom or at least one R' is a fluorine atom; different R 3 Each independently of the other is not connected or is connected through a chemical bond to form a ring; r is R 3 Wherein each of said substituted substituents is independently unconnected, or adjacent 2 substituents are linked by a chemical bond to form a ring;
The definition of R' is the same as that in claim 1;
preferably, said Z 1 、Z 2 、Z 3 、Z 4 Three of them are CR 3 The other is N;
or preferably, the Z 1 、Z 2 、Z 3 、Z 4 Are all CR 3
Further, in formula (2), the R 11 、R 12 Each independently has a structure as shown in formula (B):
Figure BDA0003395719340000052
wherein the dotted line represents the attachment site of the group;
U 1 、U 2 、U 3 、U 4 、U 5 each independently selected from CR 4 Or N;
R 4 each independently selected from the group consisting of hydrogen, halogen, C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylaminoAny one or a combination of at least two of C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl; different R 4 Each independently of the other is not connected or is connected through a chemical bond to form a ring;
preferably, the U 1 、U 2 、U 3 、U 4 、U 5 Four of them are CR 4 The other is N;
or preferably, the U 1 、U 2 、U 3 、U 4 、U 5 Are all CR 4
Still further, the compound of the present invention has a structure represented by any one of the formula (2-1), the formula (2-2) or the formula (2-3):
Figure BDA0003395719340000061
wherein X is 11 、X 12 、X 13 、X 14 、X 15 、X 16 、X 17 、X 18 、Y 11 、Y 12 、Y 13 、Y 14 、Y 15 、Y 16 、Y 17 、Y 18 Each independently selected from CR 5 Or N;
R 5 each independently selected from at least one of hydrogen, halogen, unsubstituted or R ' substituted C1-C20 straight or branched alkyl, unsubstituted or R ' substituted C3-C20 cycloalkyl, unsubstituted or R ' substituted C1-C20 alkoxy, unsubstituted or R ' substituted C1-C20 alkylsilyl, unsubstituted or R ' substituted C1-C20 alkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R ' substituted C6-C30 arylamino, unsubstituted or R ' substituted C3-C30 heteroarylamino, unsubstituted or R ' substituted C6-C30 aryloxy, unsubstituted or R ' substituted C3-C30 heteroaryloxy, unsubstituted or R ' substituted C6-C60 aryl, unsubstituted or R ' substituted C3-C60 heteroaryl, and R 5 At least one of them is fluorine atom, or at least one R' is fluorine atom, C1-C20 straight-chain or branched alkyl, C3-C20 cycloalkyl, CA combination of any of 6 to C60 aryl or C3 to C60 heteroaryl;
different R 5 Each independently of the other is not connected or is connected through a chemical bond to form a ring; r is R 5 Wherein each of said substituted substituents is independently unconnected, or adjacent 2 substituents are linked by a chemical bond to form a ring;
the definition of R' is the same as that in claim 1;
U 11 、U 12 、U 13 、U 14 、U 15 、U 16 、U 17 、U 18 、U 19 、U 20 each independently selected from CR 6 Or N; preferably U 11 、U 12 、U 13 、U 14 、U 15 、U 16 、U 17 、U 18 、U 19 、U 20 Each independently selected from CR 6
R 6 Each independently selected from any one or a combination of at least two of hydrogen, halogen, C1-C20 straight or branched chain alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl; different R 6 Each independently of the other is not connected or is connected through a chemical bond to form a ring;
preferably, the compound of the general formula has a structure represented by the formula (2-3);
Preferably, R in formula (2-1), formula (2-2) and formula (2-3) 5 When the fluorine atom is R 'is fluorine atom or R' is a combination of fluorine atom and any one of C1-C20 straight chain or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl or C3-C60 heteroaryl, the total number of fluorine atoms in the molecular structure of the compound is 1-20; more preferably, the total number of fluorine atoms in the molecular structure of the compound is 1 to 5.
Further, in the formula (2-1), the formula (2-2) and the formula (2-3):
Y 11 、Y 12 、Y 13 、Y 14 、Y 15 、Y 16 、Y 17 、Y 18 each independently selected from CR 5 And at least one R 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl, C3-C60 heteroaryl;
preferably, Y 13 、Y 17 Each independently selected from CR 5 And at least one R 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl, C3-C60 heteroaryl;
Still more preferably, Y 13 、Y 17 Each independently selected from CR 5 And at least one R 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C10 straight or branched alkyl, C3-C10 cycloalkyl, C6-C30 aryl, C3-C30 heteroaryl;
more preferably, Y 13 、Y 17 Selected from the same CR 5 And R is 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl, C3-C60 heteroaryl.
Further, the compound of the present invention has a structure represented by any one of the formula (3-1), the formula (3-2) or the formula (3-3):
Figure BDA0003395719340000071
R 11 、R 12 、R 13 、R 14 、R 15 、R 16 independently represent monosubstituted to maximum allowable numberIs a substituent of (2);
R 11 、R 12 、R 13 、R 14 each independently selected from at least one of halogen, unsubstituted or R 'substituted C1-C20 straight or branched alkyl, unsubstituted or R' substituted C3-C20 cycloalkyl, unsubstituted or R 'substituted C1-C20 alkoxy, unsubstituted or R' substituted C1-C20 alkylsilyl, unsubstituted or R 'substituted C1-C20 alkylamino, unsubstituted or R' substituted C1-C20 heteroalkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R 'substituted C6-C30 arylamino, unsubstituted or R' substituted C3-C30 heteroarylamino, unsubstituted or R 'substituted C6-C30 aryloxy, unsubstituted or R' substituted C3-C30 heteroaryloxy, unsubstituted or R 'substituted C6-C60 aryl, unsubstituted or R' substituted C3-C60 heteroaryl, and R 11 、R 12 、R 13 、R 14 At least one of which is a fluorine atom or at least one R' is a fluorine atom;
R 11 、R 12 、R 13 、R 14 each independently of the other is not connected or is connected through a chemical bond to form a ring; r is R 11 、R 12 、R 13 、R 14 Wherein each of said substituted substituents is independently unconnected, or adjacent 2 substituents are linked by a chemical bond to form a ring; the definition of R' is the same as that in claim 1;
R 15 、R 16 each independently selected from any one or a combination of at least two of hydrogen, halogen, C1-C20 straight or branched chain alkyl, C3-C20 cycloalkyl, C3-C20 heterocycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C1-C20 heteroalkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl; different R 15 R is different from R 16 Each independently of the other is not connected or is connected through a chemical bond to form a ring;
preferably, in the formula (3-1), the formula (3-2) and the formula (3-3), the total number of fluorine atoms in the molecular structure of the compound is 1 to 10; more preferably, the total number of fluorine atoms in the molecular structure of the compound is 1 to 5.
Further, in the formula (3-1), the formula (3-2) and the formula (3-3):
R 11 、R 12 、R 13 、R 14 、R 15 、R 16 At least one of which is selected from a fluorine atom, or from one of the following groups substituted by a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl, C3-C60 heteroaryl;
preferably, R 11 、R 12 、R 13 、R 14 、R 15 、R 16 Each independently represents 1 or 2 substituent groups, R 11 、R 12 、R 13 、R 14 The number of each is the same or different;
R 11 、R 12 、R 13 、R 14 at least one of which is selected from a fluorine atom, or from one of the following groups substituted by a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl, C3-C60 heteroaryl;
preferably, R 11 、R 12 、R 13 、R 14 Each independently represents 1 or 2 substituent groups, R 11 、R 12 、R 13 、R 14 The number of each is the same or different;
further preferably, R 11 、R 12 Each represents a single substituent group, and R 11 、R 12 The connection sites of the substituent groups are respectively and independently positioned at the para positions of the connection sites of the B atoms on the benzene ring connected with the connection sites, R 11 、R 12 Each independently selected from a fluorine atom, or from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl, C3-C60Heteroaryl;
still more preferably, R 11 、R 12 Each represents a single substituent group, and R 11 、R 12 The connection sites of the substituent groups are respectively and independently positioned at the para positions of the connection sites of the B atoms on the benzene ring connected with the connection sites, R 11 、R 12 Each independently selected from a fluorine atom, or from one of the following groups substituted with a fluorine atom: methylene, isopropylidene, t-butylidene, phenylene;
more preferably, R 11 、R 12 Is the same single substituent group and is simultaneously selected from fluorine atoms, or is selected from one of the following groups substituted by fluorine atoms: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl, C3-C60 heteroaryl, and R 11 、R 12 Is positioned at the para position of the B atom connecting site on the connected benzene ring;
most preferably, R 11 、R 12 Is the same single substituent group and is simultaneously selected from fluorine atoms, or is selected from one of the following groups substituted by fluorine atoms: methylene, isopropylidene, t-butylidene, and phenylene.
Further, the organic compounds of the present invention may preferably be represented by the following specific structural compounds N1 to N204, which are merely representative and do not limit the scope of the present invention:
Figure BDA0003395719340000081
/>
Figure BDA0003395719340000091
/>
Figure BDA0003395719340000101
/>
Figure BDA0003395719340000111
/>
Figure BDA0003395719340000121
/>
Figure BDA0003395719340000131
/>
Figure BDA0003395719340000141
/>
Figure BDA0003395719340000151
/>
Figure BDA0003395719340000161
/>
Figure BDA0003395719340000171
/>
Figure BDA0003395719340000181
In another aspect of the invention, there is also provided the use of a compound as described above in an organic electroluminescent device. In particular, the use as a material for a light-emitting layer in an organic electroluminescent device is preferred, more preferably as a material in a light-emitting layer in an organic electroluminescent device, and in particular as a luminescent dye can be applied.
As still another aspect of the present invention, there is also provided an organic electroluminescent device comprising a first electrode, a second electrode, and one or more organic layers interposed between the first electrode and the second electrode, wherein the organic layers contain the compound of the general formula as described above or the compound of the structures N1 to N198 as described above.
Specifically, an embodiment of the present invention provides an organic electroluminescent device including a substrate, and a first electrode, a plurality of light emitting functional layers, and a second electrode sequentially formed on the substrate; the light-emitting functional layer comprises a hole injection layer, a hole transmission layer, a light-emitting layer and an electron transmission layer, wherein the hole injection layer is formed on the anode layer, the hole transmission layer is formed on the hole injection layer, the cathode layer is formed on the electron transmission layer, and the light-emitting layer is arranged between the hole transmission layer and the electron transmission layer; wherein the light-emitting layer contains the compound with the general formula or the compound with the structures of N1 to N204.
The invention also discloses a display screen or a display panel, wherein the display screen or the display panel adopts the organic electroluminescent device; preferably, the display screen or display panel is an OLED display.
The invention also discloses electronic equipment, wherein the electronic equipment is provided with a display screen or a display panel, and the display screen or the display panel adopts the organic electroluminescent device.
The OLED device prepared by the compound has low starting voltage and better service life, and can meet the requirements of current panel manufacturing enterprises on high-performance materials.
The specific reason why the above-described compound of the present invention is excellent as a luminescent dye in a luminescent layer in an organic electroluminescent device is not clear, and it is presumed that the following reasons are possible:
1. the parent nucleus structure of the compound molecule of the invention is as follows: the para position in the central benzene ring is connected with two oxygen atoms, and simultaneously connected with two nitrogen atoms and two boron atoms. On the premise of keeping multiple resonances, the energy level split of the front line orbit generates effective red shift, so that the target molecule has high luminous efficiency and high color purity. The series of materials can obtain red light to near infrared emission.
2. The peripheral substituents in the molecular structure of the compound are not completely the same, and the compound has asymmetric characteristics, thereby being beneficial to the adjustment of the light color of materials and the improvement of the efficiency of devices.
3. The aromatic ring which is commonly connected with the boron atom and the hetero atom in the molecular structure of the compound is preferably provided with the substituent group containing the F atom at the para position of the boron atom, and the substituent group at the position is more beneficial to improving the light color red shift of a device due to the electron withdrawing effect of the F atom, adjusting the light color to the application range of mass production, reducing the sublimation temperature of the material, narrowing the spectrum possibly and improving the efficiency and the service life of the device.
In addition, the preparation process of the compound is simple and easy to implement, raw materials are easy to obtain, and the compound is suitable for mass production and amplification.
Detailed Description
Specific methods for preparing the above novel compounds of the present invention will be described below by way of example with reference to a plurality of synthesis examples, but the preparation method of the present invention is not limited to these synthesis examples.
It should be noted that, the method for obtaining the compound is not limited to the synthetic method and raw materials used in the present invention, and those skilled in the art may select other methods or routes to obtain the compound proposed in the present invention. All compounds of the synthesis process not mentioned in the present invention are commercially available starting products or are prepared by these starting products according to known methods.
The solvents and reagents used in the present invention, such as methylene chloride, petroleum ether, ethanol, t-butylbenzene, boron tribromide, carbazole, diphenylamine, etc., may be purchased from domestic chemical product markets, such as from the national pharmaceutical group reagent company, TCI company, shanghai pichia pharmaceutical company, carboline reagent company, etc.
The method for synthesizing the compound of the present invention will be briefly described.
The synthesis route is as follows:
Figure BDA0003395719340000201
analytical detection of intermediates and compounds in the present invention uses an absiex mass spectrometer (4000 QTRAP).
Synthesis example 1
Synthesis of compound N21:
Figure BDA0003395719340000202
synthesis of intermediate N21-1:
a (30 g,97.44 mmol), B (57.18 g,204.63 mmol), potassium carbonate (40.40 g,292.33 mmol) and N, N-dimethylformamide (300 ml) were put into a 1000ml three-necked flask, nitrogen was replaced 3 times, and the temperature was raised to 60℃to 70℃to react for 2 to 3 hours.
The system was cooled to room temperature, water (500 ml) was added dropwise to the system to precipitate a solid, which was filtered, and the cake was recrystallized from toluene/ethanol to give intermediate N21-1.5 g.
Synthesis of intermediate N21-2:
n21-1 (55.5 g,67.13 mmol), C (18.18 g,167.83 mmol), cesium carbonate (65.62 g,201.40 mmol), N-dimethylformamide (300 ml) were put into a 1000ml three-necked flask, nitrogen was replaced 3 times, and the temperature was raised to 100℃to react for 8 hours.
The system was cooled to room temperature, water (500 ml) was added dropwise to the system to precipitate a solid, which was filtered, and the cake was recrystallized from toluene/ethanol to give intermediate N21-2.5 g.
Synthesis of product N21:
intermediate N21-2 (25 g,24.73 mmol) was added to a 500ml three-necked flask, tert-butylbenzene (170 ml) was added, and after stirring for 20 minutes, the reaction system was cooled to 0℃and then N-butyllithium (29.68 mL,74.19 mmol) was added, and stirring was continued for 30 minutes while maintaining the low temperature. Then gradually heating to 60 ℃ and continuously heating for 2h. The reaction system temperature was again lowered to 0℃and boron tribromide (9.53 ml,98.92 mmol) was added under nitrogen protection, followed by stirring for 10 minutes and then heating to 60℃for 30 minutes. The temperature of the system was again lowered to 0deg.C and diisopropylethylamine (21.60 mL,123.65 mmol) was added. Finally, the reaction system is heated to 120 ℃ for reaction for 12 hours.
After the reaction was cooled to room temperature, the organic phase was dried under reduced pressure. Column chromatography gives 8.6g crude product, toluene/ethanol recrystallization gives 5.6g red solid with 99.12% purity. Mass spectrometry determines molecular ion mass: 868.36 (theory: 868.42).
Synthesis example 2
Synthesis of compound N23:
Figure BDA0003395719340000211
synthesis of intermediate N23-1:
synthesis of N21-1 was repeated as illustrated in the previous embodiment to obtain 57.6g of a white solid.
Synthesis of intermediate N24-2:
n23-1 (52.5 g,67.13 mmol), C (20.02 g,158.76 mmol), cesium carbonate (62.07 g,190.51 mmol), N-dimethylformamide (300 ml) were put into a 1000ml three-necked flask, nitrogen was replaced 3 times, and the temperature was raised to 100℃to react for 8 hours.
The system was cooled to room temperature, water (500 ml) was added dropwise to the system to precipitate a solid, which was filtered, and the cake was recrystallized from toluene/ethanol to give intermediate N23-2.5 g.
Synthesis of product N23:
the synthesis scheme is the same as that of N21, 7.3g of crude product is obtained by column chromatography, 4.3g of red solid is obtained by toluene/ethanol recrystallization, and the purity is 99.26%. Mass spectrometry determines molecular ion mass: 896.37 (theory: 896.45).
Synthesis example 3
Synthesis of compound N24:
Figure BDA0003395719340000221
synthesis of intermediate N24-1:
synthesis of N24-1 gave, after recrystallization, 54.6g of a white solid.
Synthesis of intermediate N24-2:
n24-1 (55.5 g,67.13 mmol), C (18.18 g,167.83 mmol), cesium carbonate (65.62 g,201.40 mmol), N-dimethylformamide (300 ml) were put into a 1000ml three-necked flask, nitrogen was replaced 3 times, and the temperature was raised to 100℃to react for 8 hours.
The system was cooled to room temperature, water (500 ml) was added dropwise to the system to precipitate a solid, which was filtered, and the cake was recrystallized from toluene/ethanol to give intermediate N24-2.2 g.
Synthesis of product N24:
the synthesis scheme is the same as that of N21, column chromatography is carried out to obtain 6.5g of crude product, toluene/ethanol recrystallization is carried out to obtain 3.7g of red solid, and the purity is 99.66%. Mass spectrometry determines molecular ion mass: 868.32 (theory: 868.42).
Synthesis example 4
Synthesis of compound N61:
Figure BDA0003395719340000231
synthesis of intermediate N61-1:
a (30 g,67.13 mmol), B (24.67 g,220.09 mmol), cesium carbonate (86.05 g,264.11 mmol) and N, N-dimethylformamide (300 ml) were put into a 1000ml three-necked flask, the mixture was purged with nitrogen 3 times, and the temperature was raised to 100℃for 8 hours.
The system was cooled to room temperature, water (500 ml) was added dropwise to the system to precipitate a solid, which was filtered, and the cake was recrystallized from toluene/ethanol to give intermediate N61-1.5 g.
Synthesis of intermediate N61-2:
n61-1 (26.5 g,50.48 mmol), C (35.52 g,126.20 mmol), sodium tert-butoxide (14.55 g,151.44 mmol), (t-Bu) 3 PHBF 4 (2.93 g,10.10 mmol), pd2 (dba) 3 (4.87 g, 5.48), toluene (300 ml) was put into a 1000ml three-necked flask, nitrogen was purged 3 times, and the temperature was raised to 110℃for reaction for 12 hours.
The system is spin-dried, the crude product is obtained by column chromatography, 32g of intermediate N61-228.5g is obtained by toluene ethanol recrystallization.
Synthesis of product N61:
intermediate N61-2 (22.5 g,24.30 mmol) was added to a 500ml three-necked flask, tert-butylbenzene (170 ml) was added, and after stirring for 20 minutes, the reaction system was cooled to 0℃and then 45.56mL,72.89mmol of tert-butyllithium was added, and stirring was continued for 30 minutes while maintaining the low temperature. Then gradually heating to 60 ℃ and continuously heating for 2h. The reaction system temperature was again lowered to 0℃and boron tribromide (9.36 ml,97.19 mmol) was added under nitrogen protection, followed by stirring for 10 minutes and then heating to 60℃for 30 minutes. Diisopropylethylamine (21.12 mL,121.49 mmol) was added again to reduce the temperature of the system to 0deg.C. Finally, the reaction system is heated to 120 ℃ for reaction for 12 hours.
After the reaction was cooled to room temperature, the organic phase was dried under reduced pressure. Column chromatography gives 6.6g crude product, toluene/ethanol recrystallization gives 3.6g red solid with 99.42% purity. Mass spectrometry determines molecular ion mass: 872.63 (theory: 872.45).
Synthesis example 5
Synthesis of compound N64:
Figure BDA0003395719340000241
synthesis of intermediate N64-1:
a (30 g,67.13 mmol), B (24.67 g,220.09 mmol), cesium carbonate (86.05 g,264.11 mmol) and N, N-dimethylformamide (300 ml) were put into a 1000ml three-necked flask, the mixture was purged with nitrogen 3 times, and the temperature was raised to 100℃for 8 hours.
The temperature of the system was lowered to room temperature, water (500 ml) was added dropwise to the system to precipitate a solid, which was filtered, and the cake was recrystallized from toluene/ethanol to give intermediate N64-1.5 g.
Synthesis of intermediate N64-2:
synthesis of N61-2 gave 28.6g of a white solid after recrystallization.
Synthesis of product N64:
the synthesis scheme is the same as that of N61, 7.2g of crude product is obtained by column chromatography, 4.1g of red solid is obtained by toluene/ethanol recrystallization, and the purity is 99.36%. Mass spectrometry determines molecular ion mass: 872.63 (theory: 872.45).
Device embodiment
Description of the embodiments
The OLED includes a first electrode and a second electrode, and an organic material layer between the electrodes. The organic material may in turn be divided into a plurality of regions. For example, the organic material layer may include a hole transport region, a light emitting layer, and an electron transport region.
In particular embodiments, a substrate may be used below the first electrode or above the second electrode. The substrates are all glass or polymer materials with excellent mechanical strength, thermal stability, water resistance and transparency. A Thin Film Transistor (TFT) may be provided on a substrate for a display.
The first electrode may be formed by sputtering or depositing a material serving as the first electrode on the substrate. When the first electrode is used as the anode, an oxide transparent conductive material such as Indium Tin Oxide (ITO), indium Zinc Oxide (IZO), tin dioxide (SnO 2), zinc oxide (ZnO), or the like, and any combination thereof may be used. When the first electrode is used as the cathode, metals or alloys such as magnesium (Mg), silver (Ag), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), ytterbium (Yb), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag), and any combinations thereof may be used.
The organic material layer may be formed on the electrode by vacuum thermal evaporation, spin coating, printing, or the like. The compounds used as the organic material layer may be small organic molecules, large organic molecules and polymers, and combinations thereof.
The hole transport region is located between the anode and the light emitting layer. The hole transport region may be a Hole Transport Layer (HTL) of a single layer structure including a single layer hole transport layer containing only one compound and a single layer hole transport layer containing a plurality of compounds. The hole transport region may have a multilayer structure including at least one of a Hole Injection Layer (HIL), a Hole Transport Layer (HTL), and an Electron Blocking Layer (EBL); wherein the HIL is located between the anode and the HTL and the EBL is located between the HTL and the light emitting layer.
The material of the hole transport region may be selected from, but is not limited to, phthalocyanine derivatives such as CuPc, conductive polymers or conductive dopant-containing polymers such as polystyrene, polyaniline/dodecylbenzenesulfonic acid (Pani/DBSA), poly (3, 4-ethylenedioxythiophene)/poly (4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphorsulfonic acid (Pani/CSA), polyaniline/poly (4-styrenesulfonate) (Pani/PSS), aromatic amine derivatives such as the compounds shown below HT-1 to HT-51; or any combination thereof.
Figure BDA0003395719340000251
/>
Figure BDA0003395719340000261
/>
Figure BDA0003395719340000271
The hole injection layer is located between the anode and the hole transport layer. The hole injection layer may be a single compound material or a combination of a plurality of compounds. For example, the hole injection layer may employ one or more of the compounds HT-1 through HT-51 described above, or one or more of the compounds HI-1-HI-3 described below; one or more compounds from HT-1 to HT-51 may also be used to dope one or more of HI-1-HI-3 described below.
Figure BDA0003395719340000272
The luminescent layer comprises luminescent dyes (i.e. dopants) that can emit different wavelength spectra, and may also comprise Host materials (Host). The light emitting layer may be a single color light emitting layer emitting a single color of red, green, blue, or the like. The plurality of monochromatic light emitting layers with different colors can be arranged in a plane according to the pixel pattern, or can be stacked together to form a color light emitting layer. When the light emitting layers of different colors are stacked together, they may be spaced apart from each other or may be connected to each other. The light emitting layer may be a single color light emitting layer capable of simultaneously emitting different colors such as red, green, and blue.
According to different technologies, the luminescent layer material can be made of different materials such as fluorescent electroluminescent material, phosphorescent electroluminescent material, thermal activation delayed fluorescence luminescent material and the like. In an OLED device, a single light emitting technology may be used, or a combination of different light emitting technologies may be used. The different luminescent materials classified by the technology can emit light of the same color, and can also emit light of different colors.
In one aspect of the present invention, the host material of the light emitting layer is selected from, but not limited to, one or more combinations of the following pH-1 to pH-85.
Figure BDA0003395719340000281
/>
Figure BDA0003395719340000291
/>
Figure BDA0003395719340000301
/>
Figure BDA0003395719340000311
In one aspect of the invention, the light-emitting layer employs a thermally activated delayed fluorescence light-emitting technique. The light emitting layer includes, in addition to a host material, a first dopant, which may be selected from, but is not limited to, a combination of one or more of TDE1-TDE49 listed below, and/or a second dopant, which is selected from a combination of one or more of the organic compounds represented by formula I.
Figure BDA0003395719340000312
/>
Figure BDA0003395719340000321
/>
Figure BDA0003395719340000331
/>
Figure BDA0003395719340000341
In one aspect of the invention, an Electron Blocking Layer (EBL) is located between the hole transport layer and the light emitting layer. The electron blocking layer may employ, but is not limited to, one or more compounds of HT-1 through HT-51 described above, or one or more compounds of PH-47 through PH-77 described above; mixtures of one or more compounds of HT-1 through HT-51 and one or more compounds of PH-47 through PH-77 may also be employed, but are not limited thereto.
The OLED organic material layer may further include an electron transport region between the light emitting layer and the cathode. The electron transport region may be an Electron Transport Layer (ETL) of a single layer structure including a single layer electron transport layer containing only one compound and a single layer electron transport layer containing a plurality of compounds. The electron transport region may also be a multilayer structure including at least one of an Electron Injection Layer (EIL), an Electron Transport Layer (ETL), and a Hole Blocking Layer (HBL).
In one aspect of the invention, the electron transport layer material may be selected from, but is not limited to, combinations of one or more of ET-1 through ET-73 listed below.
Figure BDA0003395719340000342
/>
Figure BDA0003395719340000351
/>
Figure BDA0003395719340000361
/>
Figure BDA0003395719340000371
Figure BDA0003395719340000381
In one aspect of the invention, a Hole Blocking Layer (HBL) is located between the electron transport layer and the light emitting layer. The hole blocking layer may employ, but is not limited to, one or more of the compounds ET-1 to ET-73 described above, or one or more of the compounds PH-1 to PH-46; mixtures of one or more compounds of ET-1 to ET-73 with one or more compounds of PH-1 to PH-46 may also be employed, but are not limited to.
An electron injection layer may also be included in the device between the electron transport layer and the cathode, the electron injection layer material including, but not limited to, a combination of one or more of the following.
LiQ,LiF,NaCl,CsF,Li 2 O,Cs 2 CO 3 ,BaO,Na,Li,Ca,Mg,Yb。
The preparation process of the organic electroluminescent device in this embodiment is as follows:
the procedure for making example 1 of the thermally activated delayed fluorescence device is as follows:
the glass plate coated with the ITO transparent conductive layer was sonicated in commercial cleaners, rinsed in deionized water, and rinsed in acetone: ultrasonic degreasing in ethanol mixed solvent, baking in clean environment to completely remove water, cleaning with ultraviolet light and ozone, and bombarding surface with low-energy cation beam;
placing the glass substrate with anode in vacuum chamber, vacuumizing to<1×10 -5 Pa, vacuum thermal evaporation is carried out on the anode layer film in sequence, wherein 10nm of HT-4:HI-3 (97/3,w/w) mixture is used as a hole injection layer, 60nm of compound HT-4 is used as a hole transport layer, and 5nm of compound HT-51 is used as an electron blocking layer; a ternary mixture of a 40nm compound PH54, TDE42 and N1 (100:50:1, w/w/w) as a light-emitting layer; PH-28 at 5nm was used as hole blocking layer, a 25nm mixture of compounds ET-69:ET-57 (50/50, w/w) was used as electron transport layer, liF at 1nm was used as electron injection layer, and metallic aluminum at 150nm was used as cathode. The total evaporation rate of all organic layers and LiF was controlled at 0.1 nm/sec, and the evaporation rate of the metal electrode was controlled at 1 nm/sec.
Device examples 2-14 and comparative examples 1-3 were prepared in the same manner as in device example 1 except that N1 in the light-emitting layer was replaced with N21, N22, N23, N24, N25, N41, N42, N44, N45, N197, N198, N199, N201 and compounds C1, C2 and C3 in the prior art.
Figure BDA0003395719340000382
The organic electroluminescent device prepared by the above procedure was subjected to the following performance measurement:
testing the light color of the device by testing the fluorescence emission spectrum; measuring the external quantum efficiency of the organic electroluminescent device by using an integrating sphere;
the properties of the thermally activated sensitized delayed fluorescence device prepared in each of the above examples are shown in table 1 below.
Examples Numbering of compounds Luminescence peak (nm) EQE(%)
Comparative example 1 C1 595 11.2
Comparative example 2 C2 640 6.9
Comparative example 3 C3 642 7.3
Example 1 N1 620 17.0
Example 2 N21 621 17.2
Example 3 N22 622 17.0
Example 4 N23 623 16.9
Example 5 N24 620 16.6
Example 6 N25 623 17.0
Example 7 N41 615 16.7
Example 8 N42 617 16.9
Example 9 N44 615 16.3
Example 10 N45 619 17.1
Example 11 N197 618 16.9
Example 12 N198 625 16.2
Example 13 N199 622 16.5
Example 14 N201 623 16.3
As can be seen from table 1, when the compound of the present invention is used as a dye, the light color of the comparative example compound C1 is reddish, just near 620nm, and the efficiency is higher, which may be that the light color is redshifted due to the electron withdrawing fluorine-containing group contained in the compound of the present invention, and for the compound C1, the sensitizer in the device cannot be used for complete energy transfer, thus the efficiency is lower; the comparative example compound C2 is too red in light color compared with the compound of the invention, and the existence of sulfur atoms damages the plane rows of the compound, so that the device efficiency is extremely low, and the existence of a plurality of F atoms causes the light color to be too red, so that the efficiency is reduced. Therefore, the compound of the invention meets the requirements of red light devices in light color, and has advantages in efficiency.
The foregoing description of the embodiments has been provided for the purpose of illustrating the general principles of the invention, and is not meant to limit the invention thereto, but to limit the invention thereto, and any modifications, equivalents, improvements and equivalents thereof may be made without departing from the spirit and principles of the invention.

Claims (12)

1. A compound of the general formula (1) has the structure shown in the general formula:
Figure FDA0003395719330000011
in the formula (1), Y 1 、Y 2 Each independently is N or B;
X 1 、X 2 each independently selected from NR 1 、BR 2 O or S;
ring A, ring D, ring E, ring F are each independently selected from any one of substituted or unsubstituted C6-C60 aromatic rings, substituted or unsubstituted C3-C60 heteroaromatic rings;
R 1 、R 2 each independently selected from substituted or unsubstituted C1 to C20 straight or branched chainAny one of alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C60 aryl and substituted or unsubstituted C3-C60 heteroaryl, wherein R is 1 、R 2 Each independently being unconnected to an adjacent ring structure or connected to form a ring by a chemical bond;
the substituents in ring A, ring D, ring E and ring F are each independently selected from at least one of halogen, unsubstituted or R ' substituted C1-C20 straight or branched alkyl, unsubstituted or R ' substituted C3-C20 cycloalkyl, unsubstituted or R ' substituted C1-C20 alkoxy, unsubstituted or R ' substituted C1-C20 alkylsilyl, unsubstituted or R ' substituted C1-C20 alkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R ' substituted C6-C30 arylamino, unsubstituted or R ' substituted C3-C30 heteroarylamino, unsubstituted or R ' substituted C6-C30 aryloxy, unsubstituted or R ' substituted C3-C30 heteroaryloxy, unsubstituted or R ' substituted C6-C60 aryl and unsubstituted or R ' substituted C3-C60 heteroaryl;
R' is independently selected from any one or a combination of at least two of halogen, C1-C20 straight-chain or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxyl, C1-C20 alkyl silicon base, C1-C20 alkyl amino, C6-C30 aryl amino, C3-C30 heteroaryl amino, C6-C30 aryloxy, C3-C30 heteroaryl oxy, C6-C60 aryl or C3-C60 heteroaryl;
and at least one of the substituted substituents in ring A, ring D, ring E and ring F is a fluorine atom, or at least one R' is one of a fluorine atom substituted C1-C20 straight or branched alkyl group, a fluorine atom substituted C3-C20 cycloalkyl group, a fluorine atom substituted C6-C60 aryl group or a fluorine atom substituted C3-C60 heteroaryl group;
the substituted substituents in ring A, ring D, ring E and ring F are each independently unconnected, or adjacent 2 substituents are connected into a ring through chemical bonds;
R 1 、R 2 wherein each of the substituted substituents is independently selected from the group consisting of halogen, C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, ammoniaAny one or a combination of at least two of a group, a hydroxyl group, a C1-C20 alkyl silicon group, a C1-C20 alkyl amino group, a C6-C30 aryl amino group, a C3-C30 heteroaryl amino group, a C6-C30 aryloxy group, a C3-C30 heteroaryl oxy group, a C6-C60 aryl group or a C3-C60 heteroaryl group.
2. A compound of formula (la) according to claim 1, wherein Y 1 、Y 2 Are all B;
preferably, the X 1 、X 2 At least one of them is NR 1
More preferably, the X 1 、X 2 Are all NR 1
3. The compound of formula (la) according to claim 1, wherein the compound has a structure as shown in formula (2):
Figure FDA0003395719330000021
in formula (2), ring a, ring D, ring E, ring F have the same defined ranges as in claim 1;
R a 、R b each independently selected from any one of substituted or unsubstituted C1-C20 straight or branched chain alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C6-C60 aryl, and substituted or unsubstituted C3-C60 heteroaryl;
the R is a Not attached to ring E or attached by chemical bonds to form a ring, R b Is not connected with the ring F or is connected with the ring F through a chemical bond to form a ring;
R a 、R b wherein each of the substituted substituents is independently selected from any one of halogen, C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl A combination of the two.
4. A compound of the general formula according to any one of claims 1 to 3, wherein the rings A, D, E, F each independently have a structure represented by the formula (A),
Figure FDA0003395719330000022
wherein the dashed line represents a fused bond of the group;
Z 1 、Z 2 、Z 3 、Z 4 each independently selected from CR 3 Or N;
R 3 each independently selected from at least one of hydrogen, halogen, unsubstituted or R ' substituted C1-C20 straight or branched alkyl, unsubstituted or R ' substituted C3-C20 cycloalkyl, unsubstituted or R ' substituted C1-C20 alkoxy, unsubstituted or R ' substituted C1-C20 alkylsilyl, unsubstituted or R ' substituted C1-C20 alkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R ' substituted C6-C30 arylamino, unsubstituted or R ' substituted C3-C30 heteroarylamino, unsubstituted or R ' substituted C6-C30 aryloxy, unsubstituted or R ' substituted C3-C30 heteroaryloxy, unsubstituted or R ' substituted C6-C60 aryl, unsubstituted or R ' substituted C3-C60 heteroaryl, and R 3 At least one of which is a fluorine atom or at least one R' is a fluorine atom; different R 3 Each independently of the other is not connected or is connected through a chemical bond to form a ring; r is R 3 Wherein each of said substituted substituents is independently unconnected, or adjacent 2 substituents are linked by a chemical bond to form a ring;
The definition of R' is the same as that in claim 1;
preferably, said Z 1 、Z 2 、Z 3 、Z 4 Three of them are CR 3 The other is N;
or preferably, the Z 1 、Z 2 、Z 3 、Z 4 Are all CR 3
5. A compound of formula (la) according to claim 3, wherein R a 、R b Each independently has a structure as shown in formula (B):
Figure FDA0003395719330000031
wherein the dotted line represents the attachment site of the group;
U 1 、U 2 、U 3 、U 4 、U 5 each independently selected from CR 4 Or N;
R 4 each independently selected from any one or a combination of at least two of hydrogen, halogen, C1-C20 straight or branched chain alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl; different R 4 Each independently of the other is not connected or is connected through a chemical bond to form a ring;
preferably, the U 1 、U 2 、U 3 、U 4 、U 5 Four of them are CR 4 The other is N;
or preferably, the U 1 、U 2 、U 3 、U 4 、U 5 Are all CR 4
6. A compound of the general formula according to claim 3, having a structure represented by any one of the formula (2-1), the formula (2-2) or the formula (2-3):
Figure FDA0003395719330000032
wherein X is 11 、X 12 、X 13 、X 14 、X 15 、X 16 、X 17 、X 18 、Y 11 、Y 12 、Y 13 、Y 14 、Y 15 、Y 16 、Y 17 、Y 18 Each independently selected from CR 5 Or N;
R 5 each independently selected from at least one of hydrogen, halogen, unsubstituted or R ' substituted C1-C20 straight or branched alkyl, unsubstituted or R ' substituted C3-C20 cycloalkyl, unsubstituted or R ' substituted C1-C20 alkoxy, unsubstituted or R ' substituted C1-C20 alkylsilyl, unsubstituted or R ' substituted C1-C20 alkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R ' substituted C6-C30 arylamino, unsubstituted or R ' substituted C3-C30 heteroarylamino, unsubstituted or R ' substituted C6-C30 aryloxy, unsubstituted or R ' substituted C3-C30 heteroaryloxy, unsubstituted or R ' substituted C6-C60 aryl, unsubstituted or R ' substituted C3-C60 heteroaryl, and R 5 At least one of which is a fluorine atom, or at least one R' is a combination of a fluorine atom and any one of C1-C20 straight-chain or branched-chain alkyl, C3-C20 cycloalkyl, C6-C60 aryl or C3-C60 heteroaryl;
different R 5 Each independently of the other is not connected or is connected through a chemical bond to form a ring; r is R 5 Wherein each of said substituted substituents is independently unconnected, or adjacent 2 substituents are linked by a chemical bond to form a ring;
The definition of R' is the same as that in claim 1;
U 11 、U 12 、U 13 、U 14 、U 15 、U 16 、U 17 、U 18 、U 19 、U 20 each independently selected from CR 6 Or N; preferably U 11 、U 12 、U 13 、U 14 、U 15 、U 16 、U 17 、U 18 、U 19 、U 20 Each independently selected from CR 6
R 6 Each independently selected from hydrogen, halogen, C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxyAny one or a combination of at least two of C1-C20 alkyl silicon group, C1-C20 alkyl amino group, C6-C30 aryl amino group, C3-C30 heteroaryl amino group, C6-C30 aryloxy group, C3-C30 heteroaryl oxy group, C6-C60 aryl group or C3-C60 heteroaryl group; different R 6 Each independently of the other is not connected or is connected through a chemical bond to form a ring;
preferably, the compound of the general formula has a structure represented by the formula (2-3);
preferably, R in formula (2-1), formula (2-2) and formula (2-3) 5 When the fluorine atom is R 'is fluorine atom or R' is a combination of fluorine atom and any one of C1-C20 straight chain or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl or C3-C60 heteroaryl, the total number of fluorine atoms in the molecular structure of the compound is 1-20; more preferably, the total number of fluorine atoms in the molecular structure of the compound is 1 to 10, and still more preferably, the total number of fluorine atoms in the molecular structure of the compound is 1 to 5.
7. The compound according to claim 6, wherein in formula (2-1), formula (2-2), formula (2-3):
Y 11 、Y 12 、Y 13 、Y 14 、Y 15 、Y 16 、Y 17 、Y 18 each independently selected from CR 5 And at least one R 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl, C3-C60 heteroaryl;
preferably, Y 13 、Y 17 Each independently selected from CR 5 And at least one R 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6%A C60 aryl, C3-C60 heteroaryl;
still more preferably, Y 13 、Y 17 Each independently selected from CR 5 And at least one R 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl, C3-C60 heteroaryl;
More preferably, Y 13 、Y 17 Selected from the same CR 5 And R is 5 Selected from a fluorine atom, or selected from one of the following groups substituted with a fluorine atom: C1-C10 straight or branched alkyl, C3-C10 cycloalkyl, C6-C30 aryl, C3-C30 heteroaryl.
8. A compound according to claim 3, having a structure represented by any one of formula (3-1), formula (3-2) or formula (3-3):
Figure FDA0003395719330000041
R 11 、R 12 、R 13 、R 14 、R 15 、R 16 each independently represents a substituent group monosubstituted to a maximum permissible number;
R 11 、R 12 、R 13 、R 14 each independently selected from at least one of halogen, unsubstituted or R 'substituted C1-C20 straight or branched alkyl, unsubstituted or R' substituted C3-C20 cycloalkyl, unsubstituted or R 'substituted C1-C20 alkoxy, unsubstituted or R' substituted C1-C20 alkylsilyl, unsubstituted or R 'substituted C1-C20 alkylamino, unsubstituted or R' substituted C1-C20 heteroalkylamino, cyano, nitro, hydroxy, amino, unsubstituted or R 'substituted C6-C30 arylamino, unsubstituted or R' substituted C3-C30 heteroarylamino, unsubstituted or R 'substituted C6-C30 aryloxy, unsubstituted or R' substituted C3-C30 heteroaryloxy, unsubstituted or R 'substituted C6-C60 aryl, unsubstituted or R' substituted C3-C60 heteroaryl, and R 11 、R 12 、R 13 、R 14 At least one of which is a fluorine atom or at least one R' is a fluorine atom;
R 11 、R 12 、R 13 、R 14 each independently of the other is not connected or is connected through a chemical bond to form a ring; r is R 11 、R 12 、R 13 、R 14 Wherein each of said substituted substituents is independently unconnected, or adjacent 2 substituents are linked by a chemical bond to form a ring; the definition of R' is the same as that in claim 1;
R 15 、R 16 each independently selected from any one or a combination of at least two of hydrogen, halogen, C1-C20 straight or branched chain alkyl, C3-C20 cycloalkyl, C3-C20 heterocycloalkyl, C1-C20 alkoxy, nitro, cyano, amino, hydroxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C1-C20 heteroalkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl or C3-C60 heteroaryl; different R 15 R is different from R 16 Each independently of the other is not connected or is connected through a chemical bond to form a ring;
preferably, in the formula (3-1), the formula (3-2) and the formula (3-3), the total number of fluorine atoms in the molecular structure of the compound is 1 to 10; more preferably, the total number of fluorine atoms in the molecular structure of the compound is 1 to 5.
9. The compound of claim 8, wherein in formula (3-1), formula (3-2), formula (3-3):
R 11 、R 12 、R 13 、R 14 At least one of which is selected from a fluorine atom, or from one of the following groups substituted by a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C1-C20 alkoxy, C1-C20 alkylsilyl, C1-C20 alkylamino, C6-C30 arylamino, C3-C30 heteroarylamino, C6-C30 aryloxy, C3-C30 heteroaryloxy, C6-C60 aryl, C3-C60 heteroaryl;
preferably, R 11 、R 12 、R 13 、R 14 Independently of each other, represents 1 or 2 substituentsGroup R 11 、R 12 、R 13 、R 14 The number of each is the same or different;
further preferably, R 11 、R 12 Each represents a single substituent group, and R 11 、R 12 The connection sites of the substituent groups are respectively and independently positioned at the para positions of the connection sites of the B atoms on the benzene ring connected with the connection sites, R 11 、R 12 Each independently selected from a fluorine atom, or from one of the following groups substituted with a fluorine atom: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl, C3-C60 heteroaryl;
still more preferably, R 11 、R 12 Each represents a single substituent group, and R 11 、R 12 The connection sites of the substituent groups are respectively and independently positioned at the para positions of the connection sites of the B atoms on the benzene ring connected with the connection sites, R 11 、R 12 Each independently selected from a fluorine atom, or from one of the following groups substituted with a fluorine atom: methylene, isopropylidene, t-butylidene, phenylene;
More preferably, R 11 、R 12 Is the same single substituent group and is simultaneously selected from fluorine atoms, or is selected from one of the following groups substituted by fluorine atoms: C1-C20 straight or branched alkyl, C3-C20 cycloalkyl, C6-C60 aryl, C3-C60 heteroaryl, and R 11 、R 12 Is positioned at the para position of the B atom connecting site on the connected benzene ring;
most preferably, R 11 、R 12 Is the same single substituent group and is simultaneously selected from fluorine atoms, or is selected from one of the following groups substituted by fluorine atoms: methylene, isopropylidene, t-butylidene, and phenylene.
10. The compound of claim 1, having the structure shown below:
Figure FDA0003395719330000051
/>
Figure FDA0003395719330000061
/>
Figure FDA0003395719330000071
/>
Figure FDA0003395719330000081
/>
Figure FDA0003395719330000091
/>
Figure FDA0003395719330000101
/>
Figure FDA0003395719330000111
/>
Figure FDA0003395719330000121
/>
Figure FDA0003395719330000131
/>
Figure FDA0003395719330000141
/>
Figure FDA0003395719330000151
11. use of a compound of the general formula according to any one of claims 1 to 10 as a functional material in an organic electronic device comprising an organic electroluminescent device, an optical sensor, a solar cell, a lighting element, an organic thin film transistor, an organic field effect transistor, an organic thin film solar cell, an information tag, an electronic artificial skin sheet, a sheet scanner or an electronic paper;
preferably, the organic compound is used as a light-emitting layer material in an organic electroluminescent device, more preferably as a light-emitting dye in a light-emitting layer.
12. An organic electroluminescent device comprising a first electrode, a second electrode, and one or more light-emitting functional layers interposed between the first electrode and the second electrode, wherein the light-emitting functional layers contain the organic compound according to any one of claims 1 to 10;
preferably, the light-emitting functional layer comprises an electron blocking layer and at least one of a hole injection layer, a hole transport layer, a light-emitting layer and an electron transport layer, and the light-emitting layer contains the organic compound according to any one of claims 1 to 10.
CN202111483347.2A 2021-12-07 2021-12-07 Boron-containing organic compound and application thereof Pending CN116239615A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111483347.2A CN116239615A (en) 2021-12-07 2021-12-07 Boron-containing organic compound and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111483347.2A CN116239615A (en) 2021-12-07 2021-12-07 Boron-containing organic compound and application thereof

Publications (1)

Publication Number Publication Date
CN116239615A true CN116239615A (en) 2023-06-09

Family

ID=86628166

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111483347.2A Pending CN116239615A (en) 2021-12-07 2021-12-07 Boron-containing organic compound and application thereof

Country Status (1)

Country Link
CN (1) CN116239615A (en)

Similar Documents

Publication Publication Date Title
CN112142605B (en) Compound and application thereof, and organic electroluminescent device comprising compound
CN113511978A (en) Compound, application thereof and organic electroluminescent device adopting compound
KR20220084156A (en) Boron-containing compound and organic electroluminescent device comprising same
CN115304492A (en) Compound and application thereof
CN116462595A (en) Organic compound and application thereof
CN116854597A (en) Organic compound and application thereof
CN115160342A (en) Compound, application thereof and organic electroluminescent device comprising compound
CN114478267A (en) Organic compound for light emitting device and organic electroluminescent device
CN113929646A (en) Organic compound and organic electroluminescent device
CN116239615A (en) Boron-containing organic compound and application thereof
CN116715685A (en) Organic compound, application thereof and organic electroluminescent device comprising same
CN116262761A (en) Boron-nitrogen-containing organic compound and application thereof
CN117126183A (en) Organic compound and application thereof, and organic electroluminescent device comprising organic compound
CN116253750A (en) Organic compound and application thereof
CN117285551A (en) Boron-containing organic compound and application thereof
CN116178404A (en) Boron-containing organic compound and application thereof
CN117003775A (en) Boron-containing organic compound and application thereof
CN118126069A (en) Boron-containing organic compound and application thereof
CN116969979A (en) Organic compound and application thereof
CN118255793A (en) Organic compound and application thereof, and organic electroluminescent device comprising organic compound
WO2022089415A1 (en) Novel boron-containing organic compound and application thereof
CN116925111A (en) Organic compound and application thereof
CN117247400A (en) Organic compound and application thereof, and organic electroluminescent device comprising organic compound
CN118165015A (en) Boron-containing organic compound and application thereof
CN116987104A (en) Organic compound and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination